Body weight as a predictor of antidepressant efficacy in the GENDEP project

Journal of Affective Disorders

Volumn 118, Issue 1-3, 2009, Pages 147-154

  Uher, Rudolf ^a   Mors, Ole ^b   Hauser, Joanna ^c   Rietschel, Marcella ^d   Maier, Wolfgang ^e   Kozel, Dejan ^f   Henigsberg, Neven ^g   Souery, Daniel ^h   Placentino, Anna ⁱ   Perroud, Nader ^a   Dernovsek, Moica Zvezdana ^j   Strohmaier, Jana ^d   Larsen, Erik Roj ^b   Zobel, Astrid ^e   Leszczynska Rodziewicz, Anna ^c   Kalember, Petra ^g   Pedrini, Laura ⁱ   Linotte, Sylvie ^h   Gunasinghe, Cerisse ^a   Aitchison, Katherine J ^a   McGuffin, Peter ^a   Farmer, Anne ^a   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^e UNIVERSITY OF BONN   (Germany)

^f NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

^g UNIVERSITY OF ZAGREB   (Croatia)

^h ERASME HOSPITAL   (Belgium)

ⁱ IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^j Educational and Research Institute Ozara   (Slovenia)

more..

Author keywords

Antidepressant medication; Body mass index; Body weight; Depression; Psychopharmacology; Psychosomatics

Indexed keywords

ESCITALOPRAM; NORTRIPTYLINE;

ADULT; APPETITE DISORDER; ARTICLE; AUTONOMIC NEUROPATHY; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; OBESITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SYMPTOMATOLOGY; TREATMENT RESPONSE;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; APPETITE; BODY MASS INDEX; BODY WEIGHT; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NORTRIPTYLINE; OBESITY; OVERWEIGHT; SLEEP; TREATMENT OUTCOME;

EID: 69949156578     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.02.013     Document Type: Article

References (32)

1. Bagby R.M., Ryder A.G., Schuller D.R., and Marshall M.B. The Hamilton Depression Rating Scale: has the gold standard become a lead weight?. Am. J. Psychiatry 161 (2004) 2163-2177
2. Bech P. Rating scales in depression: limitations and pitfalls. Dialogues Clin. Neurosci. 8 (2006) 207-215
3. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961) 561-571
4. Blaine B. Does depression cause obesity?: a meta-analysis of longitudinal studies of depression and weight control. J. Health Psychol. 13 (2008) 1190-1197
5. Carpenter K.M., Hasin D.S., Allison D.B., and Faith M.S. Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study. Am. J. Public Health 90 (2000) 251-257
6. Farmer A., Korszun A., Owen M.J., Craddock N., Jones L., Jones I., Gray J., Williamson R.J., and McGuffin P. Medical disorders in people with recurrent depression. Br. J. Psychiatry 192 (2008) 351-355
7. Greenblatt D.J., von Moltke L.L., Harmatz J.S., and Shader R.I. Pharmacokinetics, pharmacodynamics and drug disposition. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology: 5th Generation of Progress (2002), Lippincott Williams & Wilkins, Philadelphia
8. Gueorguieva R., and Krystal J.H. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch. Gen. Psychiatry 61 (2004) 310-317
9. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Clin. Psychol. 6 (1967) 278-296
10. Khan A., Schwartz K.A., Kolts R.L., and Brown W.A. BMI, sex, and antidepressant response. J. Affect. Disord. 99 (2007) 101-106
11. Kloiber S., Ising M., Reppermund S., Horstmann S., Dose T., Majer M., Zihl J., Pfister H., Unschuld P.G., Holsboer F., and Lucae S. Overweight and obesity affect treatment response in major depression. Biol. Psychiatry 62 (2007) 321-326
12. Kruijshaar M.E., Hoeymans N., Bijl R.V., Spijker J., and Essink-Bot M.L. Levels of disability in major depression: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). J. Affect. Disord. 77 (2003) 53-64
13. Lane P. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches. Pharm. Stat. 7 (2008) 93-106
14. Lim W., Thomas K.S., Bardwell W.A., and Dimsdale J.E. Which measures of obesity are related to depressive symptoms and in whom?. Psychosomatics 49 (2008) 23-28
15. Mallinckrodt C.H., Clark W.S., and David S.R. Accounting for dropout bias using mixed-effects models. J. Biopharm. Stat. 11 (2001) 9-21
16. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
17. Nierenberg A.A. Predictors of response to antidepressants general principles and clinical implications. Psychiatr. Clin. North Am. 26 (2003) 345-352 (viii)
18. NIH. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes. Res. 6 Suppl 2 (1998) 51S-209S
19. Pagoto S., Bodenlos J.S., Kantor L., Gitkind M., Curtin C., and Ma Y. Association of major depression and binge eating disorder with weight loss in a clinical setting. Obesity 15 (2007) 2557-2559 (Silver. Spring)
20. Papakostas G.I., Petersen T., Iosifescu D.V., Burns A.M., Nierenberg A.A., Alpert J.E., Rosenbaum J.F., and Fava M. Obesity among outpatients with major depressive disorder. Int. J. Neuropsychopharmacol. 8 (2005) 59-63
21. Raftery A.E. Bayesian model selection in social research. Sociol. Method. 25 (1995) 111-163
22. Sanchez C., Bergqvist P.B., Brennum L.T., Gupta S., Hogg S., Larsen A., and Wiborg O. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology (Berl.) 167 (2003) 353-362
23. Sanchez C., and Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell. Mol. Neurobiol. 19 (1999) 467-489
24. Schneider K.L., Bodenlos J.S., Ma Y., Olendzki B., Oleski J., Merriam P., Crawford S., Ockene I.S., and Pagoto S.L. Design and methods for a randomized clinical trial treating comorbid obesity and major depressive disorder. BMC Psychiat. 8 (2008) 77
25. Schwartz G. Estimating the dimension of a model. Ann. Stat. 5 (1978) 461-464
26. Smith R., Ronald J., Delaive K., Walld R., Manfreda J., and Kryger M.H. What are obstructive sleep apnea patients being treated for prior to this diagnosis?. Chest 121 (2002) 164-172
27. Thissen D., Chen W.H., and Bock D. MULTILOG 7 (2003), SSI Scientific Software International, Lincolnwood, USA
28. Uher R., Farmer A., Maier W., Rietschel M., Hauser J., Marusic A., Mors O., Elkin A., Williamson R.J., Schmael C., Henigsberg N., Perez J., Mendlewicz J., Janzing J.G., Zobel A., Skibinska M., Kozel D., Stamp A.S., Bajs M., Placentino A., Barreto M., McGuffin P., and Aitchison K.J. Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol. Med. 38 (2008) 289-300
29. Uher R., Maier W., Hauser J., Marusic A., Schmael C., Mors O., Henigsberg N., Souery D., Placentino A., Rietschel M., Zobel A., Dmitrzak-Weglarz M., Petrovic A., Jorgensen L., Kalember P., Govannini C., Barreto M., Elkin A., Landau S., Farmer A., Aitchison K.J., and McGuffin P. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br. J. Psychiatry 194 (2009) 252-259
30. Walsh B.T., Seidman S.N., Sysko R., and Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287 (2002) 1840-1847
31. WHO. Obesity: preventing and managing the global epidemic. Report of a World Health Organisation Consultation on Obesity, Geneva, 3-5 June 1997 (1998), World Health Organisation, Geneva
32. Wing J.K., Sartorius N., and Ustin T.B. Diagnosis and Clinical Measurement in Psychiatry. A Reference Manual for SCAN (1998), World Health Organization, Geneva